BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29709615)

  • 21. A microfiber scaffold-based 3D in vitro human neuronal culture model of Alzheimer's disease.
    Ranjan VD; Qiu L; Lee JW; Chen X; Jang SE; Chai C; Lim KL; Tan EK; Zhang Y; Huang WM; Zeng L
    Biomater Sci; 2020 Sep; 8(17):4861-4874. PubMed ID: 32789337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease.
    Oksanen M; Petersen AJ; Naumenko N; Puttonen K; Lehtonen Š; Gubert Olivé M; Shakirzyanova A; Leskelä S; Sarajärvi T; Viitanen M; Rinne JO; Hiltunen M; Haapasalo A; Giniatullin R; Tavi P; Zhang SC; Kanninen KM; Hämäläinen RH; Koistinaho J
    Stem Cell Reports; 2017 Dec; 9(6):1885-1897. PubMed ID: 29153989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell models of Alzheimer's disease: progress and challenges.
    Arber C; Lovejoy C; Wray S
    Alzheimers Res Ther; 2017 Jun; 9(1):42. PubMed ID: 28610595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simplified and sensitive method to identify Alzheimer's disease biomarker candidates using patient-derived induced pluripotent stem cells (iPSCs).
    Shirotani K; Matsuo K; Ohtsuki S; Masuda T; Asai M; Kutoku Y; Ohsawa Y; Sunada Y; Kondo T; Inoue H; Iwata N
    J Biochem; 2017 Dec; 162(6):391-394. PubMed ID: 28992104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells.
    Armijo E; Gonzalez C; Shahnawaz M; Flores A; Davis B; Soto C
    Neurosci Lett; 2017 Feb; 639():74-81. PubMed ID: 28034781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal Differentiation of Induced Pluripotent Stem Cells from Schizophrenia Patients in Two-Dimensional and in Three-Dimensional Cultures Reveals Increased Expression of the Kv4.2 Subunit DPP6 That Contributes to Decreased Neuronal Activity.
    Naujock M; Speidel A; Fischer S; Kizner V; Dorner-Ciossek C; Gillardon F
    Stem Cells Dev; 2020 Dec; 29(24):1577-1587. PubMed ID: 33143549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mitochondria cluster at the proximal axon initial segment controls axodendritic TAU trafficking in rodent primary and human iPSC-derived neurons.
    Tjiang N; Zempel H
    Cell Mol Life Sci; 2022 Feb; 79(2):120. PubMed ID: 35119496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
    Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced Neuronal Activity and Asynchronous Calcium Transients Revealed in a 3D Organoid Model of Alzheimer's Disease.
    Yin J; VanDongen AM
    ACS Biomater Sci Eng; 2021 Jan; 7(1):254-264. PubMed ID: 33347288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Synergistic Engineering Approach to Build Human Brain Spheroids.
    von Maydell D; Jorfi M
    Methods Mol Biol; 2021; 2258():151-169. PubMed ID: 33340360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes.
    Raja WK; Mungenast AE; Lin YT; Ko T; Abdurrob F; Seo J; Tsai LH
    PLoS One; 2016; 11(9):e0161969. PubMed ID: 27622770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.
    Mungenast AE; Siegert S; Tsai LH
    Mol Cell Neurosci; 2016 Jun; 73():13-31. PubMed ID: 26657644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors.
    Lagomarsino VN; Pearse RV; Liu L; Hsieh YC; Fernandez MA; Vinton EA; Paull D; Felsky D; Tasaki S; Gaiteri C; Vardarajan B; Lee H; Muratore CR; Benoit CR; Chou V; Fancher SB; He A; Merchant JP; Duong DM; Martinez H; Zhou M; Bah F; Vicent MA; Stricker JMS; Xu J; Dammer EB; Levey AI; Chibnik LB; Menon V; Seyfried NT; De Jager PL; Noggle S; Selkoe DJ; Bennett DA; Young-Pearse TL
    Neuron; 2021 Nov; 109(21):3402-3420.e9. PubMed ID: 34473944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Aβ Deposition in a Mouse Model of Alzheimer's Disease.
    Cha MY; Kwon YW; Ahn HS; Jeong H; Lee YY; Moon M; Baik SH; Kim DK; Song H; Yi EC; Hwang D; Kim HS; Mook-Jung I
    Stem Cells Transl Med; 2017 Jan; 6(1):293-305. PubMed ID: 28170178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus.
    Jayaraman A; Htike TT; James R; Picon C; Reynolds R
    Acta Neuropathol Commun; 2021 Sep; 9(1):159. PubMed ID: 34625123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
    Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
    Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.
    Israel MA; Yuan SH; Bardy C; Reyna SM; Mu Y; Herrera C; Hefferan MP; Van Gorp S; Nazor KL; Boscolo FS; Carson CT; Laurent LC; Marsala M; Gage FH; Remes AM; Koo EH; Goldstein LS
    Nature; 2012 Jan; 482(7384):216-20. PubMed ID: 22278060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient derivation of cortical glutamatergic neurons from human pluripotent stem cells: a model system to study neurotoxicity in Alzheimer's disease.
    Vazin T; Ball KA; Lu H; Park H; Ataeijannati Y; Head-Gordon T; Poo MM; Schaffer DV
    Neurobiol Dis; 2014 Feb; 62():62-72. PubMed ID: 24055772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
    Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
    J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.